Access keys

Skip to content Accessibility Home News, events and publications Site map Search Privacy policy Help Contact us Terms of use

Synthetic Biology ERA-NET - 1st joint call

Co-funding

In collaboration with 12 European countries and the USA

Funding total

BBSRC has made £2.6M available for the UK component of funded the consortia, with a funding total pot for all participating countries around £13.5M. Please see further details in the list of awards document below.

Number of projects funded

8.

Previous awards (PDF 196KB)

You may need to download additional plug-ins to open this file.

Purpose

To build European Synthetic Biology capacity through innovative transnational projects.

Key aims

The projects could originate from one or more of the following scientific (sub) fields:

  • Metabolic engineering: Attaining new levels of complexity in modification of biosynthetic pathways for sustainable chemistry.
  • Regulatory circuits: Inserting well-characterised, modular, artificial networks to provide new functions in cells and organisms.
  • Orthogonal biosystems: Engineering cells to expand the genetic code to develop new information storage and processing capacity (xeno nucleic acids) and protein engineering.
  • Bionanoscience: Developing molecular-scale motors and other components for cell-based machines or cell-free devices to perform complex new tasks.
  • Minimal genomes: Identifying the smallest number of parts needed for life as a basis for engineering minimal cell factories for new functions.
  • Protocells: Using programmable chemical design to produce (semi-)synthetic cells

Applications where expected to demonstrate multidisciplinarity with the primary focus of the UK component of joint applications falling within our remit.